Hantz Financial Services Inc. Reduces Holdings in Encompass Health Corporation $EHC

Hantz Financial Services Inc. reduced its position in Encompass Health Corporation (NYSE:EHC) by 13.9% in the 3rd quarter, Holdings Channel reports. The firm owned 66,242 shares of the company’s stock after selling 10,658 shares during the quarter. Hantz Financial Services Inc.’s holdings in Encompass Health were worth $8,414,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Tectonic Advisors LLC raised its position in shares of Encompass Health by 1.6% in the third quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after buying an additional 82 shares during the last quarter. Global Retirement Partners LLC increased its holdings in shares of Encompass Health by 23.0% in the third quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock valued at $57,000 after purchasing an additional 84 shares during the last quarter. EP Wealth Advisors LLC lifted its position in Encompass Health by 2.4% during the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock worth $453,000 after buying an additional 88 shares in the last quarter. Natural Investments LLC lifted its position in Encompass Health by 1.2% during the third quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock worth $991,000 after buying an additional 89 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its stake in Encompass Health by 1.1% during the third quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock worth $1,044,000 after buying an additional 91 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Up 1.4%

Shares of NYSE:EHC opened at $95.64 on Thursday. The firm has a market capitalization of $9.62 billion, a PE ratio of 18.08, a price-to-earnings-growth ratio of 1.52 and a beta of 0.73. Encompass Health Corporation has a 1 year low of $92.53 and a 1 year high of $127.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.14 and a quick ratio of 1.14. The firm’s 50-day moving average is $104.81 and its two-hundred day moving average is $114.55.

Analysts Set New Price Targets

A number of analysts have issued reports on EHC shares. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Barclays raised their price objective on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $142.86.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.